Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A subacute progressive symmetric sensorial and/or motor disorder characterized by muscular weakness with impaired sensation, absent or diminished tendon reflexes and elevated cerebrospinal fluid (CSF) proteins. SIDP is an intermediate form between Guillain-Barre syndrome (GBS) and chronic inflammatory demyelinating polyneuropathy (CIDP).
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for subacute inflammatory demyelinating polyneuropathy.
5 publications have been identified in PubMed for subacute inflammatory demyelinating polyneuropathy. Research spans Case Report / Case Series (100%).
Sharma R (2026). [PMID: 41743127](https://pubmed.ncbi.nlm.nih.gov/41743127/). *Case reports in neurological medicine*. [Case Report / Case Series]
Smith K (2026). [PMID: 41675029](https://pubmed.ncbi.nlm.nih.gov/41675029/). *JAAD case reports*. [Case Report / Case Series]
Uyanık HU (2025). [PMID: 39575870](https://pubmed.ncbi.nlm.nih.gov/39575870/). *Muscle & nerve*. [Case Report / Case Series]
Wu S (2025). [PMID: 40235678](https://pubmed.ncbi.nlm.nih.gov/40235678/). *Oncology letters*. [Case Report / Case Series]
Turčanová Koprušáková M (2025). [PMID: 41188793](https://pubmed.ncbi.nlm.nih.gov/41188793/). *BMC neurology*. [Case Report / Case Series]
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 8:40 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center